Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk Viva Biotech Holdings per 2025 Jun 30 adalah 1,836.70 MM.
- Nilai operating income untuk Viva Biotech Holdings per 2025 Jun 30 adalah 228.61 MM.
- Nilai net income untuk Viva Biotech Holdings per 2025 Jun 30 adalah 172.29 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 1,836.70 | 228.61 | 172.29 |
2025-03-31 | 1,911.68 | 229.14 | 169.79 |
2024-12-31 | 1,986.65 | 229.67 | 167.29 |
2024-09-30 | 1,990.93 | 207.17 | 83.49 |
2024-06-30 | 1,995.22 | 184.67 | -0.32 |
2024-03-31 | 2,075.40 | 188.68 | -58.22 |
2023-12-31 | 2,155.58 | 192.68 | -116.11 |
2023-09-30 | 2,284.32 | 241.38 | -276.19 |
2023-06-30 | 2,413.07 | 290.07 | -436.26 |
2023-03-31 | 2,396.35 | 278.03 | -482.37 |
2022-12-31 | 2,379.63 | 265.98 | -528.48 |
2022-09-30 | 2,283.01 | 229.93 | -208.57 |
2022-06-30 | 2,186.38 | 193.88 | 111.33 |
2022-03-31 | 2,145.23 | 215.39 | 199.44 |
2021-12-31 | 2,104.08 | 236.90 | 287.55 |
2021-09-30 | 1,814.97 | 227.44 | 257.98 |
2021-06-30 | 1,525.85 | 217.98 | 228.41 |
2021-03-31 | 1,111.40 | 165.26 | -79.23 |
2020-12-31 | 696.96 | 112.54 | -386.88 |
2020-09-30 | 537.62 | 86.57 | -348.89 |
2020-06-30 | |||
2020-03-31 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | ||
2024-06-30 | -0.00 | -0.09 |
2024-03-31 | -0.03 | -0.12 |
2023-12-31 | -0.06 | -0.14 |
2023-09-30 | -0.14 | -0.19 |
2023-06-30 | -0.23 | -0.23 |
2023-03-31 | -0.25 | -0.25 |
2022-12-31 | -0.28 | -0.28 |
2022-09-30 | -0.11 | -0.14 |
2022-06-30 | 0.06 | -0.01 |
2022-03-31 | 0.10 | 0.04 |
2021-12-31 | 0.15 | 0.08 |
2021-09-30 | 0.14 | 0.10 |
2021-06-30 | 0.13 | 0.12 |
2021-03-31 | -0.05 | -0.05 |
2020-12-31 | -0.25 | -0.25 |
2020-09-30 | -0.23 | -0.23 |
2020-06-30 | -0.21 | -0.21 |
2020-03-31 | -0.02 | -0.01 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Viva Biotech Holdings per 2025 Jun 30 adalah 351.48 MM.
- Nilai cash from investing activities untuk Viva Biotech Holdings per 2025 Jun 30 adalah -29.84 MM.
- Nilai kas dari aktivitas pendanaan untuk Viva Biotech Holdings per 2025 Jun 30 adalah -455.14 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | 351.48 | -29.84 | -455.14 |
2025-03-31 | 362.74 | 78.03 | -556.45 |
2024-12-31 | 373.99 | 185.90 | -657.76 |
2024-09-30 | 296.14 | 459.04 | -791.27 |
2024-06-30 | 218.29 | 732.19 | -924.77 |
2024-03-31 | 300.85 | 585.68 | -677.13 |
2023-12-31 | 383.40 | 439.17 | -429.50 |
2023-09-30 | 497.14 | 77.50 | -207.75 |
2023-06-30 | 610.88 | -284.18 | 14.01 |
2023-03-31 | 498.47 | -328.49 | -64.60 |
2022-12-31 | 386.05 | -372.80 | -143.20 |
2022-09-30 | 269.20 | -285.11 | -18.40 |
2022-06-30 | 152.34 | -197.42 | 106.40 |
2022-03-31 | 115.09 | -533.13 | -273.38 |
2021-12-31 | 77.83 | -868.84 | -653.16 |
2021-09-30 | 59.09 | -2,459.08 | 1,318.82 |
2021-06-30 | 40.35 | -4,049.32 | 3,290.80 |
2021-03-31 | 41.77 | -3,949.24 | 4,299.02 |
2020-12-31 | 43.18 | -3,849.16 | 5,307.24 |
2020-09-30 | 48.78 | -2,363.41 | 3,194.32 |
2020-06-30 | |||
2020-03-31 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 | |||
2020-06-30 | |||
2020-03-31 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | ||
2024-06-30 | ||
2024-03-31 | ||
2023-12-31 | ||
2023-09-30 | ||
2023-06-30 | ||
2023-03-31 | ||
2022-12-31 | ||
2022-09-30 | ||
2022-06-30 | ||
2022-03-31 | ||
2021-12-31 | ||
2021-09-30 | ||
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 | ||
2020-09-30 | ||
2020-06-30 | ||
2020-03-31 |
Efektivitas Manajemen
- roa untuk Viva Biotech Holdings pada 2025 Jun 30 adalah 0.02.
- roe untuk Viva Biotech Holdings pada 2025 Jun 30 adalah 0.05.
- roic untuk Viva Biotech Holdings pada 2025 Jun 30 adalah 0.03.
- croic untuk Viva Biotech Holdings pada 2025 Jun 30 adalah -0.02.
- ocroic untuk Viva Biotech Holdings pada 2025 Jun 30 adalah 0.07.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | 0.02 | 0.05 | 0.03 | -0.02 | 0.07 |
2025-03-31 | 0.02 | 0.04 | 0.03 | 0.00 | 0.00 |
2024-12-31 | -0.00 | 0.05 | -0.00 | -0.01 | 0.04 |
2024-09-30 | 0.01 | 0.02 | -0.00 | -0.01 | 0.04 |
2024-06-30 | -0.01 | -0.02 | -0.02 | 0.06 | 0.07 |
2024-03-31 | -0.02 | 0.06 | 0.11 | ||
2023-12-31 | -0.03 | -0.08 | -0.04 | 0.05 | 0.08 |
2023-09-30 | -0.05 | -0.11 | -0.07 | 0.06 | 0.09 |
2023-06-30 | -0.06 | -0.11 | -0.07 | 0.06 | 0.09 |
2023-03-31 | -0.06 | -0.12 | -0.07 | 0.02 | 0.08 |
2022-12-31 | 0.01 | -0.05 | -0.03 | -0.01 | 0.04 |
2022-09-30 | 0.01 | -0.05 | -0.03 | -0.01 | 0.04 |
2022-06-30 | 0.04 | 0.03 | 0.02 | 0.01 | 0.02 |
2022-03-31 | 0.04 | 0.05 | 0.03 | -0.11 | 0.02 |
2021-12-31 | 0.03 | 0.08 | 0.05 | -0.24 | 0.01 |
2021-09-30 | 0.03 | 0.07 | 0.04 | -0.19 | 0.01 |
2021-06-30 | 0.07 | 0.12 | 0.04 | -0.14 | 0.01 |
2021-03-31 | -0.02 | -0.04 | -0.01 | 0.04 | 0.01 |
2020-12-31 | -0.20 | -0.22 | -0.06 | 0.21 | 0.00 |
2020-09-30 | -0.18 | -0.20 | -0.05 | 0.12 | 0.01 |
2020-06-30 | -0.17 | -0.18 | -0.13 | 0.11 | 0.02 |
2020-03-31 | -0.01 | -0.01 | -0.01 | 0.21 | 0.02 |
Gross Margins
- marjin kotor untuk Viva Biotech Holdings pada 2025 Jun 30 adalah 0.35.
- marjin bersih untuk Viva Biotech Holdings pada 2025 Jun 30 adalah 0.08.
- marjin operasi untuk Viva Biotech Holdings pada 2025 Jun 30 adalah 0.12.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | 0.35 | 0.08 | 0.12 |
2025-03-31 | 0.35 | 0.08 | 0.12 |
2024-12-31 | 0.34 | -0.00 | 0.09 |
2024-09-30 | 0.34 | -0.00 | 0.09 |
2024-06-30 | 0.34 | -0.05 | 0.09 |
2024-03-31 | 0.34 | -0.05 | 0.09 |
2023-12-31 | 0.35 | -0.12 | 0.11 |
2023-09-30 | 0.36 | -0.18 | 0.12 |
2023-06-30 | 0.34 | -0.18 | 0.12 |
2023-03-31 | 0.34 | -0.20 | 0.12 |
2022-12-31 | 0.31 | -0.09 | 0.10 |
2022-09-30 | 0.31 | -0.09 | 0.10 |
2022-06-30 | 0.31 | 0.05 | 0.09 |
2022-03-31 | 0.31 | 0.09 | 0.10 |
2021-12-31 | 0.34 | 0.14 | 0.11 |
2021-09-30 | 0.34 | 0.14 | 0.13 |
2021-06-30 | 0.34 | 0.15 | 0.14 |
2021-03-31 | 0.37 | -0.07 | 0.15 |
2020-12-31 | 0.44 | -0.56 | 0.16 |
2020-09-30 | 0.45 | -0.65 | 0.16 |
2020-06-30 | 0.49 | -0.82 | 0.16 |
2020-03-31 | 0.48 | -0.06 | 0.16 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) |